Literature DB >> 33283080

Molecular role of cytochrome P4501A enzymes inoxidative stress.

Rachel Stading1, Chun Chu1, Xanthi Couroucli1, Krithika Lingappan1, Bhagavatula Moorthy1.   

Abstract

Cytochrome P4501A (CYP1A) enzymes play important roles in xenobiotic and endobiotic metabolism. Due to uncoupling reactions during the enzymatic cycle, CYP1A enzymes can release reactive oxidative species (ROS) in the form of superoxide radical, hydrogen peroxide, hydroxyl radical etc. An imbalance between production of free radicals and the ability of antioxidants to detoxify the free radicals can lead to accumulation of ROS, which in turn can lead to oxidative stress. Oxidative stress can lead to inflammation and toxicity, which in turn can cause human diseases such as bronchopulmonary disease (BPD), ARDS, renal hypertension, etc. CYP1A enzymes, depending on the organ system, they either contribute or protect against oxidative injury. Thus, they have dual roles in regard to oxidative stress. This review presents an overview of the mechanistic relationship between CYP1A enzymes and oxidative stress in relation to various diseases in different organs (e.g., liver, lungs, heart, kidneys, and reproductive organs).

Entities:  

Keywords:  Cytochrome P450 1A (CYP1A) enzymes; epoxyeicosatrienoic acid (EETs); hydroxyeicosatetraenoic acid (HETEs); oxidative stress; reaction uncoupling; reactive oxygen species (ROS)

Year:  2020        PMID: 33283080      PMCID: PMC7709944          DOI: 10.1016/j.cotox.2020.07.001

Source DB:  PubMed          Journal:  Curr Opin Toxicol        ISSN: 2468-2020


  55 in total

1.  Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole.

Authors:  B Moorthy; K M Parker; C V Smith; J R Bend; S E Welty
Journal:  J Pharmacol Exp Ther       Date:  2000-02       Impact factor: 4.030

Review 2.  Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.

Authors:  Zhong Li; Yuanyuan Jiang; F Peter Guengerich; Li Ma; Shengying Li; Wei Zhang
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.157

3.  Sex-specific differences in hyperoxic lung injury in mice: implications for acute and chronic lung disease in humans.

Authors:  Krithika Lingappan; Weiwu Jiang; Lihua Wang; Xanthi I Couroucli; Roberto Barrios; Bhagavatula Moorthy
Journal:  Toxicol Appl Pharmacol       Date:  2013-06-21       Impact factor: 4.219

4.  Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A.

Authors:  Krithika Lingappan; Weiwu Jiang; Lihua Wang; Xanthi I Couroucli; Bhagavatula Moorthy
Journal:  Toxicology       Date:  2015-02-19       Impact factor: 4.221

Review 5.  CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies.

Authors:  Qiang Ma; Anthony Y H Lu
Journal:  Drug Metab Dispos       Date:  2007-04-12       Impact factor: 3.922

6.  Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.

Authors:  Jan Neckář; Libor Kopkan; Zuzana Husková; František Kolář; František Papoušek; Herbert J Kramer; Sung Hee Hwang; Bruce D Hammock; John D Imig; Jiří Malý; Ivan Netuka; Bohuslav Ošťádal; Luděk Červenka
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

7.  3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats.

Authors:  Mona E Aboutabl; Beshay N M Zordoky; Ayman O S El-Kadi
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

8.  Induction of cytochrome P450 1A1 and 1A2 by hyperoxia.

Authors:  T Okamoto; M Mitsuhashi; I Fujita; R K Sindhu; Y Kikkawa
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

9.  Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.

Authors:  Zuzana Honetschlägerová; Kento Kitada; Zuzana Husková; Alexandra Sporková; Libor Kopkan; Marcela Bürgelová; Šárka Varcabová; Akira Nishiyama; Sung Hee Hwang; Bruce D Hammock; John D Imig; Herbert J Kramer; Petr Kujal; Zdenka Vernerová; Luděk Červenka
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

10.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more
  4 in total

1.  Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility.

Authors:  Debleena Guin; Saroj Yadav; Priyanka Singh; Pooja Singh; Sarita Thakran; Samiksha Kukal; Neha Kanojia; Priyanka Rani Paul; Bijay Pattnaik; Viren Sardana; Sandeep Grover; Yasha Hasija; Luciano Saso; Anurag Agrawal; Ritushree Kukreti
Journal:  Infect Genet Evol       Date:  2022-05-08       Impact factor: 4.393

2.  Exploring optimal Taxol® CYP725A4 activity in Saccharomyces cerevisiae.

Authors:  Behnaz Nowrouzi; Liang Lungang; Leonardo Rios-Solis
Journal:  Microb Cell Fact       Date:  2022-09-19       Impact factor: 6.352

3.  Cinchona officinalis Phytochemicals-Loaded Iron Oxide Nanoparticles Induce Cytotoxicity and Stimulate Apoptosis in MCF-7 Human Breast Cancer Cells.

Authors:  Laila Naif Al-Harbi; Ghedier M Al-Shammari; Pandurangan Subash-Babu; Mohammed A Mohammed; Roaa Ahmed Alkreadees; Abu ElGasim Ahmed Yagoub
Journal:  Nanomaterials (Basel)       Date:  2022-09-28       Impact factor: 5.719

4.  Role of Human NADPH Quinone Oxidoreductase (NQO1) in Oxygen-Mediated Cellular Injury and Oxidative DNA Damage in Human Pulmonary Cells.

Authors:  Rebecca Burke; Chun Chu; Guo-Dong Zhou; Vasanta Putluri; Nagireddy Putluri; Rachel E Stading; Xanthi Couroucli; Krithika Lingappan; Bhagavatula Moorthy
Journal:  Oxid Med Cell Longev       Date:  2021-10-15       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.